Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
Carisma Therapeutics Closes Merger with Sesen Bio
Nia JulianMarch 8, 2023
Facebook0 Twitter Pinterest0 0 Likes
Previous

ReCode Raises $260M in Series B Financing to Advance Lead Programs

Nia JulianSeptember 20, 2023
Next

Ensoma Announces $85 Million Financing and Agreement to Acquire Twelve Bio to Advance Portfolio of In Vivo Engineered Cellular Medicines

Nia JulianJanuary 5, 2023

© 2020 Solasta Ventures. All Rights Reserved.